Terms: = Lung cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
2306 results:
1. Alectinib in Resected
Wu YL; Dziadziuszko R; Ahn JS; Barlesi F; Nishio M; Lee DH; Lee JS; Zhong W; Horinouchi H; Mao W; Hochmair M; de Marinis F; Migliorino MR; Bondarenko I; Lu S; Wang Q; Ochi Lohmann T; Xu T; Cardona A; Ruf T; Noe J; Solomon BJ;
N Engl J Med; 2024 Apr; 390(14):1265-1276. PubMed ID: 38598794
[TBL] [Abstract] [Full Text] [Related]
2. High risk of lung cancer in surfactant-related gene variant carriers.
Brudon A; Legendre M; Mageau A; Bermudez J; Bonniaud P; Bouvry D; Cadranel J; Cazes A; Crestani B; Dégot T; Delestrain C; Diesler R; Epaud R; Philippot Q; Théou-Anton N; Kannengiesser C; Ba I; Debray MP; Fanen P; Manali E; Papiris S; Nathan N; Amselem S; Gondouin A; Guillaumot A; Andréjak C; Jouneau S; Beltramo G; Uzunhan Y; Galodé F; Westeel V; Mehdaoui A; Hirschi S; Leroy S; Marchand-Adam S; Nunes H; Picard C; Prévot G; Reynaud-Gaubert M; De Vuyst P; Wemeau L; Defossez G; Zalcman G; Cottin V; Borie R;
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38575158
[TBL] [Abstract] [Full Text] [Related]
3. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
[TBL] [Abstract] [Full Text] [Related]
4. lung cancer Diagnoses and Outcomes During the Syrian War, 2011-2018.
Hanafi I; Abo Samra D; Alsaqqa R; Naeem A; Shebli B; Ajlyakin G
JAMA Netw Open; 2024 Mar; 7(3):e242091. PubMed ID: 38477917
[TBL] [Abstract] [Full Text] [Related]
5. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in lung cancer Radiotherapy.
Choi W; Jia Y; Kwak J; Werner-Wasik M; Dicker AP; Simone NL; Storozynsky E; Jain V; Vinogradskiy Y
JCO Clin Cancer Inform; 2024 Mar; 8():e2300241. PubMed ID: 38452302
[TBL] [Abstract] [Full Text] [Related]
6. Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.
Wang RR; Li MJ; Peng Q; Huang ZY; Wu LL; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38426334
[TBL] [Abstract] [Full Text] [Related]
7. Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
Jin X; Pan Y; Zhai C; Shen H; You L; Pan H
Sci Rep; 2024 Feb; 14(1):4793. PubMed ID: 38413705
[TBL] [Abstract] [Full Text] [Related]
8. Time between imaging and surgery is not a risk factor for upstaging of clinical stage IA non-small-cell lung cancer.
Barcelos RR; Sugarbaker E; Kennedy KF; McAllister M; Kim S; Herrera-Zamora J; Leo R; Swanson S; Ugalde Figueroa P
Eur J Cardiothorac Surg; 2024 Feb; 65(2):. PubMed ID: 38407382
[TBL] [Abstract] [Full Text] [Related]
9. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
[TBL] [Abstract] [Full Text] [Related]
10. Ductal prostate cancer staging: Role of PSMA PET/CT.
Pepe P; Pepe L; Curduman M; Pennisi M; Fraggetta F
Arch Ital Urol Androl; 2024 Feb; 96(1):12132. PubMed ID: 38363231
[TBL] [Abstract] [Full Text] [Related]
11. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis.
Zhang KD; Jost E; Panse J; Herwartz R; Lindemann-Docter K; Jonigk D; Kricheldorf K; Köchel A; Sauerbrunn N; Brümmendorf TH; Koschmieder S; Isfort S
Ann Hematol; 2024 Apr; 103(4):1149-1158. PubMed ID: 38336973
[TBL] [Abstract] [Full Text] [Related]
12. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Malignant Lymphoma of the Bile Duct Mimicking Cholangiocarcinoma].
Saeki S; Tokumitsu Y; Shindo Y; Matsui H; Nakajima M; Kimura Y; Iida M; Suzuki N; Takeda S; Ioka T; Nagano H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1627-1629. PubMed ID: 38303363
[TBL] [Abstract] [Full Text] [Related]
14. Surgeon experience does not influence nodal upstaging during vats lobectomy: Results from a large prospective national database.
Chiappetta M; Lococo F; Sperduti I; Tabacco D; Sassorossi C; Curcio C; Crisci R; Meacci E; Rea F; Margaritora S;
Surgery; 2024 May; 175(5):1408-1415. PubMed ID: 38302325
[TBL] [Abstract] [Full Text] [Related]
15. A pancancer analysis of the clinical and genomic characteristics of multiple primary cancers.
Zhang B; He L; Zhou C; Cheng X; Li Q; Tang Y; Li F; Huang T; Tu S
Sci Rep; 2024 Jan; 14(1):2367. PubMed ID: 38287125
[TBL] [Abstract] [Full Text] [Related]
16. Secondary Analysis of the Rate of Second Primary lung cancer From cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell lung cancer.
Stinchcombe TE; Wang X; Damman B; Mentlick J; Landreneau R; Wigle D; Jones DR; Conti M; Ashrafi AS; Liberman M; de Perrot M; Mitchell JD; Keenan R; Bauer T; Miller D; Altorki N
J Clin Oncol; 2024 Apr; 42(10):1110-1113. PubMed ID: 38215351
[No Abstract] [Full Text] [Related]
17. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell lung cancer: A Nonrandomized Controlled Trial.
Wu TC; Luterstein E; Neilsen BK; Goldman JW; Garon EB; Lee JM; Felix C; Cao M; Tenn SE; Low DA; Kupelian PA; Steinberg ML; Lee P
JAMA Oncol; 2024 Mar; 10(3):352-359. PubMed ID: 38206614
[TBL] [Abstract] [Full Text] [Related]
18. CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.
Lou H; Wu Z; Wei G
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186304
[TBL] [Abstract] [Full Text] [Related]
19. Impact of preoperative [
Lin JT; Li XM; Zhong WZ; Hou QY; Liu CL; Yu XY; Ye KY; Cheng YL; Du JY; Sun YQ; Zhang FG; Yan HH; Liao RQ; Dong S; Jiang BY; Liu SY; Wu YL; Yang XN
Ann Nucl Med; 2024 Mar; 38(3):188-198. PubMed ID: 38145431
[TBL] [Abstract] [Full Text] [Related]
20. Dabrafenib plus trametinib in unselected advanced BRAF V600-mut melanoma: a non-interventional, multicenter, prospective trial.
Richtig E; Nguyen VA; Koelblinger P; Wolf I; Kehrer H; Saxinger W; Ressler JM; Weinlich G; Meyersburg D; Hafner C; Jecel-Grill E; Kofler J; Lange-Asschenfeldt B; Weihsengruber F; Rappersberger K; Svastics N; Gasser K; Seeber A; Kratochvill F; Nagler S; Mraz B; Hoeller C
Melanoma Res; 2024 Apr; 34(2):142-151. PubMed ID: 38092013
[TBL] [Abstract] [Full Text] [Related]
[Next]
